We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $5.13B
1-Year Est. Return 11.51%
This Fund
S&P 500
This Quarter Est. Return
+10.31%
1 Year Est. Return
+11.51%
3 Year Est. Return
+68.19%
5 Year Est. Return
+90.4%
10 Year Est. Return
+384.43%
AUM
$3.83B
AUM Growth
+$365M
Cap. Flow
+$14.3M
Cap. Flow %
0.37%
Top 10 Hldgs %
46.82%
Holding
177
New
6
Increased
30
Reduced
82
Closed
1

Top Buys

Rank Stock Value
1
RUSHA icon
Rush Enterprises Class A
RUSHA
+$20M
2
LH icon
Labcorp
LH
+$18.1M
3
SCHW
Charles Schwab
SCHW
+$10.1M
4
ZWS icon
Zurn Elkay Water Solutions
ZWS
+$9.96M
5
WAT icon
Waters Corp
WAT
+$3.78M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$15.9M
2
MSFT icon
Microsoft
MSFT
+$14.2M
3
WMS icon
Advanced Drainage Systems
WMS
+$7.62M
4
MA icon
Mastercard
MA
+$3.36M
5
MDXG icon
MiMedx Group
MDXG
+$3.01M

Sector Composition

Rank Sector Weight
1 Financials 38.94%
2 Technology 13.69%
3 Healthcare 13.2%
4 Communication Services 7.58%
5 Industrials 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BKI
101
DELISTED
Black Knight, Inc. Common Stock
BKI
$927K 0.02%
15,525
-11,600
-43% -$651K
FTRE icon
102
Fortrea Holdings
FTRE
$1.88B
$901K 0.02%
+26,500
New +$882K
SHEL icon
103
Shell
SHEL
$283B
$891K 0.02%
14,757
-1,000
-6% -$60K
IDXX icon
104
Idexx Laboratories
IDXX
$40.2B
$879K 0.02%
1,750
-100
-5% -$47.9K
ADP icon
105
Automatic Data Processing
ADP
$110B
$845K 0.02%
3,845
-126
-3% -$27.2K
FAST icon
106
Fastenal
FAST
$56.7B
$826K 0.02%
28,000
– –
JPM.PRC icon
107
JPMorgan Chase & Co 6.00% Series EE Preferred Stock
JPM.PRC
$1.76B
$799K 0.02%
31,412
– –
MCD icon
108
McDonald's
MCD
$179B
$746K 0.02%
2,500
– –
CBSH icon
109
Commerce Bancshares
CBSH
$8.39B
$724K 0.02%
17,205
– –
BNY
110
Bank of New York Mellon
BNY
$105B
$713K 0.02%
16,013
– –
TMO icon
111
Thermo Fisher Scientific
TMO
$237B
$700K 0.02%
1,341
– –
COP icon
112
ConocoPhillips
COP
$170B
$618K 0.02%
5,961
-149
-2% -$15.3K
BB icon
113
BlackBerry
BB
$4.57B
$615K 0.02%
111,250
-700
-0.6% -$3.39K
TSLA icon
114
Tesla
TSLA
$1.41T
$593K 0.02%
2,265
-60
-3% -$12K
TSCO icon
115
Tractor Supply
TSCO
$17.2B
$589K 0.02%
13,325
-3,300
-20% -$151K
CHCO icon
116
City Holding Co
CHCO
$2.04B
$561K 0.01%
6,239
-220
-3% -$20K
KMI icon
117
Kinder Morgan
KMI
$68.5B
$499K 0.01%
28,975
-2,975
-9% -$50.5K
IEX icon
118
IDEX
IEX
$16.4B
$484K 0.01%
2,250
– –
UNH icon
119
UnitedHealth
UNH
$337B
$483K 0.01%
1,004
– –
GIS icon
120
General Mills
GIS
$19.6B
$460K 0.01%
6,000
– –
CARR icon
121
Carrier Global
CARR
$45.8B
$449K 0.01%
9,024
– –
PAYX icon
122
Paychex
PAYX
$42.1B
$447K 0.01%
4,000
– –
BMY icon
123
Bristol-Myers Squibb
BMY
$130B
$445K 0.01%
6,957
-390
-5% -$26.2K
ACN icon
124
Accenture
ACN
$118B
$440K 0.01%
1,426
– –
NVS icon
125
Novartis
NVS
$263B
$424K 0.01%
4,200
– –
3 4
5
6 7

Similar funds

ACM
AKRE Capital Management Middleburg, Virginia $5.12B AUM 19.08% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5.14B AUM 6.88% 1-Year Est. Return
CFO
Callan Family Office Radnor, Pennsylvania $5.11B AUM 35.28% 1-Year Est. Return
SB
SIG Brokerage New York $5.15B AUM 78.53% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $5.1B AUM 214.22% 1-Year Est. Return
KACA
Kayne Anderson Capital Advisors Los Angeles, California $5.1B AUM 17.16% 1-Year Est. Return

Beck Mack & Oliver's Q2 2023 Portfolio in Review

As of Q2 2023, Beck Mack & Oliver held 177 positions worth $3.83B, up 11% from $3.46B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 4%. Beck Mack & Oliver opened 6 new positions and exited 1, leaving the 177-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 39% a quarter earlier, followed by Technology and Healthcare.

  • Beck Mack & Oliver's largest Q2 2023 buy was Rush Enterprises Class A: 818,228 shares worth $22.1M.
  • Beck Mack & Oliver added most to Labcorp in Q2 2023, an estimated $18.1M increase.
  • Beck Mack & Oliver's biggest Q2 2023 reduction was Teva Pharmaceuticals, cutting an estimated $15.9M.
  • Beck Mack & Oliver fully exited CAE Inc in Q2 2023, selling an estimated $224K.
  • Beck Mack & Oliver's ten largest holdings make up 47% of its $3.83B portfolio in Q2 2023.
  • Beck Mack & Oliver opened 6 new positions and closed 1 in Q2 2023.
  • Beck Mack & Oliver's portfolio value rose 11% quarter-over-quarter to $3.83B.

Based on Beck Mack & Oliver's 13F filing for Q2 2023, filed 8 Aug 2023.